Related Experiment Video
Updated: Mar 18, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Mapping and evaluation of global and country-specific cardiovascular disease risk prediction models
Samina Akhtar1, Zainab Samad1, Gerald S Bloomfield2
1Department of Medicine, Aga Khan University, Karachi, Pakistan.
Insights
Cardiovascular disease (CVD) risk models vary in accuracy across populations. Developing locally validated, population-specific models is crucial for equitable CVD risk assessment and prevention worldwide.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Cardiovascular diseases (CVDs) are a major global health burden.
- Accurate CVD risk prediction is essential for effective prevention strategies.
- Existing risk models show variable performance across diverse populations.
Purpose of the Study:
- To systematically review and evaluate global and country-specific CVD risk prediction models.
- To identify strengths, limitations, and applicability of current models.
- To inform future development of more accurate and equitable risk assessment tools.
Main Methods:
- A comprehensive literature search was performed using PubMed and Google Scholar.
- Thirty relevant studies detailing CVD risk prediction models were selected and analyzed.
- Models were evaluated based on their risk factors, discrimination (C-statistics), and validation across different cohorts.
Main Results:
- Most CVD risk models utilize traditional factors like age, sex, blood pressure, cholesterol, and smoking.
- Discrimination (C-statistics 0.66–0.80) and validation were moderate to good, but applicability varied.
- Global models like WHO/ISH and Globorisk offer regional calibration; country-specific models showed superior performance due to local data integration.
Conclusions:
- Existing CVD risk models face challenges with population variability, underrepresentation of certain groups, and exclusion of novel risk factors.
- Country-specific and regionally calibrated models demonstrate better performance than generic global models.
- Future research should focus on developing and validating localized, population-specific CVD risk models for equitable global health outcomes.
Abstract:
Cardiovascular diseases (CVDs) remain a leading cause of global morbidity and mortality, requiring precise risk prediction models for effective prevention and management. This review maps and evaluates globally utilized and country-specific CVD risk prediction models, including the Framingham Risk Score, Pooled Cohort Equations, PREVENT, WHO/ISH Risk Charts, INTERHEART, and SCORE2. A structured literature search was conducted using PubMed and Google Scholar, from which 30 relevant studies were selected. Most of the models integrate traditional risk factors such as age, sex, blood pressure, cholesterol, and smoking status to estimate CVD risk. While these models demonstrate moderate to good discrimination (C-statistics ranging from 0.66 to 0.80) and validation, their applicability varies across populations, with concerns about overestimation or underestimation in non-original cohorts. Notably, the WHO/ISH and Globorisk models address global diversity by incorporating regional calibrations, making them suitable for low- and middle-income countries. Similarly, the country-specific risk scores outperform global models due to their incorporation of local socio-demographics. Limitations persist across existing models, including the underrepresentation of younger individuals, ethnic minorities, and the exclusion of emerging risk factors. Future efforts must prioritize the development of locally validated, population-specific models to support equitable and effective CVD risk assessment and prevention.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

